PL4069690T3 - Polimorfy triazolowego związku przeciwgrzybiczego pc945 - Google Patents

Polimorfy triazolowego związku przeciwgrzybiczego pc945

Info

Publication number
PL4069690T3
PL4069690T3 PL20824979.7T PL20824979T PL4069690T3 PL 4069690 T3 PL4069690 T3 PL 4069690T3 PL 20824979 T PL20824979 T PL 20824979T PL 4069690 T3 PL4069690 T3 PL 4069690T3
Authority
PL
Poland
Prior art keywords
polymorphs
antifungal compound
triazole antifungal
triazole
compound
Prior art date
Application number
PL20824979.7T
Other languages
English (en)
Polish (pl)
Inventor
Christopher John Wallis
Gerald Steele
Suzanne BUTTAR
Osama SULEIMAN
Julian Northen
John Mykytiuk
Jamie MARSHALL
Original Assignee
Pulmocide Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulmocide Limited filed Critical Pulmocide Limited
Publication of PL4069690T3 publication Critical patent/PL4069690T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20824979.7T 2019-12-06 2020-12-04 Polimorfy triazolowego związku przeciwgrzybiczego pc945 PL4069690T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1917867.2A GB201917867D0 (en) 2019-12-06 2019-12-06 Polymorphs
PCT/GB2020/053107 WO2021111142A1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945

Publications (1)

Publication Number Publication Date
PL4069690T3 true PL4069690T3 (pl) 2025-03-10

Family

ID=69171938

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20824979.7T PL4069690T3 (pl) 2019-12-06 2020-12-04 Polimorfy triazolowego związku przeciwgrzybiczego pc945

Country Status (26)

Country Link
US (1) US12491182B2 (enExample)
EP (2) EP4069690B1 (enExample)
JP (1) JP2023505227A (enExample)
KR (1) KR20220110726A (enExample)
CN (1) CN114746415B (enExample)
AU (1) AU2020397613A1 (enExample)
BR (1) BR112022006259A2 (enExample)
CA (1) CA3155829A1 (enExample)
CL (1) CL2022001464A1 (enExample)
CO (1) CO2022007808A2 (enExample)
DK (1) DK4069690T3 (enExample)
ES (1) ES3000984T3 (enExample)
FI (1) FI4069690T3 (enExample)
GB (1) GB201917867D0 (enExample)
HR (1) HRP20250042T1 (enExample)
HU (1) HUE069799T2 (enExample)
IL (1) IL293401A (enExample)
LT (1) LT4069690T (enExample)
MX (1) MX2022006654A (enExample)
PL (1) PL4069690T3 (enExample)
PT (1) PT4069690T (enExample)
RS (1) RS66401B1 (enExample)
SA (1) SA522432879B1 (enExample)
SI (1) SI4069690T1 (enExample)
SM (1) SMT202400514T1 (enExample)
WO (1) WO2021111142A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2963625C (en) 2014-12-05 2023-08-22 Pulmocide Limited 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses
CN117510488B (zh) * 2022-07-28 2025-12-05 博瑞制药(苏州)有限公司 一种硫酸艾沙康唑的制备方法
CN117330660A (zh) * 2023-09-14 2024-01-02 广州医科大学附属第一医院(广州呼吸中心) Uplc-ms/ms联用检测艾沙康唑的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
WO1989004829A1 (en) 1987-11-20 1989-06-01 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
AU681753B2 (en) 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
AU5928096A (en) 1995-06-02 1996-12-18 Schering Corporation Tetrahydrofuran antifungals
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
EP1372394A1 (en) 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2013036866A1 (en) 2011-09-07 2013-03-14 The Johns Hopkins University Itraconazole analogs and use thereof
CA2963625C (en) * 2014-12-05 2023-08-22 Pulmocide Limited 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses

Also Published As

Publication number Publication date
SA522432879B1 (ar) 2025-01-26
WO2021111142A1 (en) 2021-06-10
US12491182B2 (en) 2025-12-09
EP4509179A3 (en) 2025-02-26
HUE069799T2 (hu) 2025-04-28
AU2020397613A1 (en) 2022-06-02
JP2023505227A (ja) 2023-02-08
CN114746415A (zh) 2022-07-12
CL2022001464A1 (es) 2023-03-24
IL293401A (en) 2022-07-01
LT4069690T (lt) 2025-01-10
US20230028714A1 (en) 2023-01-26
BR112022006259A2 (pt) 2022-06-21
SI4069690T1 (sl) 2025-03-31
PT4069690T (pt) 2024-12-13
RS66401B1 (sr) 2025-02-28
KR20220110726A (ko) 2022-08-09
GB201917867D0 (en) 2020-01-22
DK4069690T3 (da) 2025-01-20
CO2022007808A2 (es) 2022-06-30
ES3000984T3 (es) 2025-03-04
MX2022006654A (es) 2022-09-07
EP4069690B1 (en) 2024-11-13
SMT202400514T1 (it) 2025-01-14
HRP20250042T1 (hr) 2025-03-14
EP4069690A1 (en) 2022-10-12
FI4069690T3 (fi) 2025-01-21
CN114746415B (zh) 2025-04-11
EP4509179A2 (en) 2025-02-19
CA3155829A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
ZA202106194B (en) Fungicidal compounds
GB202019810D0 (en) Compound
IL304845A (en) Pyrimidopyran compounds
PT4069690T (pt) Polimorfos do composto antifúngico de triazol pc945
ZA202210434B (en) Herbicidal compounds
IL284564A (en) Polymorphic forms of a modified quinoline-type bridged piperidine compound
GB201910665D0 (en) Novel form of compounds
ZA201707682B (en) Polymorphs of a pges-1 inhibiting triazolone compound
GB202320058D0 (en) Fungicidal compounds
GB202319974D0 (en) Fungicidal compounds
GB202319972D0 (en) Fungicidal compounds
GB202319978D0 (en) Fungicidal compounds
GB202312796D0 (en) Fungicidal compounds
GB202117362D0 (en) Herbicidal compounds
GB202117363D0 (en) Herbicidal compounds
GB202114509D0 (en) Herbicidal compounds
GB202114510D0 (en) Herbicidal compounds
GB202213186D0 (en) Herbicidal compounds
GB202213184D0 (en) Herbicidal compounds
GB202208329D0 (en) Compound
GB202204673D0 (en) Compound
GB202117834D0 (en) Compound
GB202117836D0 (en) Compound
GB201910664D0 (en) Novel forms of compound
GB202012143D0 (en) Herbicidal compounds